Molly #Polygon

🚨 Canara Robeco AMC IPO: Fully OFS, steady growth, but fully priced 🚨 📅 IPO Dates: Oct 9–13, 2025 💰 Issue Size: ₹1,326 Cr (100% OFS) 💸 Price Band: ₹253–₹266 📦 Lot Size: 56 shares (~₹14,896) 📈 Valuation: ~₹11,000–₹11,500 Cr post-issue 🔥 GMP: ~₹15–₹16 (≈6% premium) ✅ Strengths - Legacy & Trust: Established in 1993, backed by Canara Bank and Robeco (Orix Europe) → strong parentage and credibility. - Steady Financial Growth: Revenue rose from ₹204.8 Cr (FY23) → ₹404 Cr (FY25); PAT from ₹79 Cr → ₹190.7 Cr. Q1 FY26 also shows YoY growth. - High Profitability Metrics: 3-year average RoNW ~31%, consistent EPS growth, dividend-paying track record. - Industry Tailwinds: Rising SIP inflows, financialization of savings, and growing mutual fund penetration in India. - Diversified Product Mix: Equity, debt, and hybrid schemes across 26 funds; AUM ~₹1.11 lakh Cr. - Distribution Strength: Multi-channel presence (banks, IFAs, digital platforms) ensures wide investor reach. - Dividend Policy: Adopted in March 2025, with payouts in FY23–FY25, signaling shareholder-friendly approach. ⚠️ Weaknesses / Risks - 100% OFS: Entire IPO proceeds go to selling shareholders; no fresh capital for expansion. - Valuation Concerns: P/E ~27.8x (FY25) and ~21.7x (annualized FY26) → fully priced compared to peers. - Cyclical Business: Revenue and profits are market-linked; downturns in equity markets can hit earnings. - Equity-Heavy AUM: ~65% in equities → higher volatility in adverse market conditions. - Competition: Faces strong rivals like HDFC AMC, Nippon AMC, UTI AMC, and SBI MF with larger scale and stronger retail recall. - PAT Yield: Margins appear modest (0.14–0.20% in FY23–FY25, 0.05% in Q1 FY26), suggesting efficiency challenges. - P/BV Premium: At 8.03x, priced higher than book value, leaving little cushion for valuation comfort. 📊 Financial Performance - FY23: Income ₹204.8 Cr | PAT ₹79 Cr - FY24: Income ₹318.8 Cr | PAT ₹151 Cr - FY25: Income ₹404 Cr | PAT ₹190.7 Cr - Q1 FY26: Income ₹121.3 Cr | PAT ₹61 Cr (vs ₹51 Cr YoY) ✅ Steady growth in top & bottom line - Avg EPS (3 yrs): ₹7.96 - Avg RoNW: 30.97% - P/BV: 8.03 (NAV ₹33.13, June 2025) - P/E: 27.8x (FY25), 21.7x (annualized FY26) → fully priced - PAT Yield: 0.14% (FY23), 0.20% (FY24), 0.18% (FY25), 0.05% (Q1 FY26) 💸 Dividend Policy - FY23: 50% - FY24: 75% - FY25: 25% - Adopted formal dividend policy (Mar 2025) 📊 Peer Comparison (P/E multiples) - HDFC AMC: 45.6x - Nippon Life AMC: 41.2x - ABSLAMC: 24.4x - UTI AMC: ~24–25x - Canara Robeco AMC: 21.7–27.8x → priced in line, not cheap ⚖️ Verdict - Strengths: Legacy AMC (since 1993), JV of Canara Bank & Robeco, AUM ~₹1.11 lakh Cr, strong distribution, consistent profitability, dividend-paying. - Risks: Entirely OFS (no fresh funds), modest GMP (~6%), cyclical business, equity-heavy AUM (~65%), priced at par with larger peers despite smaller scale. 👉 For listing gains: Limited upside (GMP ~6%). 👉 For long-term: Stable franchise, credible parentage, but valuation leaves little margin of safety. #CanaraRobecoIPO #IPOIndia #StockMarketIndia #IPOReview #GreyMarketPremium #MutualFunds #InvestSmart #FinanceWithFree #IPOAnalysis #StockMarketTips #FinancialFreedom #ipoallotment #IPOGMP #ipo #canarabank

IPO DECODED 🧐: Canara HSBC Life Insurance IPO is open for subscription! Backed by banking giants, this company has a strong foothold in the insurance space. But is the price right? Here’s a deep dive to help you decide. 🧵👇 📋 IPO Details: * IPO Dates: Oct 10 - Oct 14, 2025 * Price Band: ₹100 - ₹106 per share * Issue Size: ₹2,517.50 cr * Type: 100% Offer For Sale (OFS) - Important: The company receives NO funds from this IPO. It's a complete exit for existing shareholders. ✅ The Strengths: Why It's Attractive * Powerful Promoters: Promoted by Canara Bank & HSBC. This gives them an unparalleled "bancassurance" network with access to over 15,700 branches, a massive advantage for customer acquisition. * Growing Bottom Line: While revenue is inconsistent, the company's Profit After Tax (PAT) has grown at a solid 13.26% CAGR from FY23 to FY25. * Strong Financials: The Embedded Value (EV), a key metric for insurers, is consistently rising. * High Solvency Ratio: At 200.42%, it's well above the regulatory requirement of 150%, indicating a strong ability to meet its long-term obligations. 🚩 The Weaknesses: Major Red Flags * Aggressive Valuation: This is the biggest concern. The issue is priced at a P/E ratio of ~125x based on FY25 earnings. * Expensive Compared to Peers: Listed giants trade at much lower valuations. * SBI Life: ~71 P/E * HDFC Life: ~86 P/E * ICICI Pru Life: ~68 P/E * Inconsistent Top Line: The company's total income has fluctuated, showing a lack of steady revenue growth. * Pure OFS: Since no money is going to the company, there's no IPO capital to fuel future growth or expansion. 📉 Valuation & Market Sentiment (GMP) * Price to Book (P/BV): The issue is priced at a P/BV of 6.54, which is on the higher side. * Grey Market Premium (GMP): The GMP is currently hovering at a mere ~1%. This is a very weak signal from the unlisted market and indicates extremely low interest for listing gains. There's a high probability of a flat or even negative listing. ⚖️ Final Verdict: Should You Apply? This IPO presents a classic case of a good business offered at a very high price. * For Listing Gains? It looks like a clear AVOID. The aggressive valuation and near-zero GMP suggest there's little to no money left on the table for short-term investors. * For Long-Term Investment? This is a pure long-term story. The strength lies in its promoter backing and bancassurance model. However, a post-listing price correction is highly possible given the valuation. Only well-informed investors with surplus cash and a 3-5 year horizon should consider it, perhaps waiting to buy after listing. Decision: Apply with extreme caution, primarily for the long term, or skip entirely for now. #IPO #CanaraHSBCIPO #IPOAlert #StockMarket #Investment #Finance #IndianStockMarket #StockToWatch #CanaraBank #HSBC #ipoallotment #IPOGMP #FinancewithFree

Dar ka mahol hai TATA capital ipo mein Allotment meaning negative listing in this IPO #GMP #tatacapital #ipo #IPOMeme #IPOAllotment #ipomemes #trading #StockMarketMeme #stockmarket #viral #IPOGMP #IPOAlert

🚨 Tata Capital IPO: Listing Day Strategy 🚨 India’s biggest IPO of 2025. ₹15,512 Cr. But will it deliver? 👇 🟢 If Allotted - Listed at ₹330+? Book partial gains. - Flat or discount (<₹326)? Hold for 1–2 sessions. Exit if ₹315 breaks with volume. - Long-term hold only if Q2 shows sustained profit + debt reduction. 🔴 If Not Allotted - Don’t chase on listing day. - Wait for Q2 earnings before entry. - Track net profit, NIMs, and debt-to-equity ratio. 📊 Snapshot: - GMP: ₹0–₹7 (muted) - Subscription: 1.96x overall (QIB 3.42x, Retail 1.10x) - 100% OFS = no fresh capital - FY25 PAT: ₹2,438 Cr | ROE: 14.6% 📌 Verdict: Strong fundamentals, but listing pop may be capped. Retweet to help others avoid FOMO 💸 #IPO #TataCapital #ListingStrategy #StockMarketIndia #FinanceWithFree #DalalStreet #Sebi #ipoinvestor #ipoalert #ipolisting #ipoallotment

Big week of earnings 🔔 Eyes on India’s heavyweights—tech, banks, and infra. Volatility, insights, and allocation pivots incoming 👀 📅 Earnings Calendar 🟢 Mon 13: HCL Tech 🟡 Tue 14: Tech Mahindra, ICICI Pru, IREDA 🔵 Wed 15: Axis Bank, HDFC Life 🟣 Thu 16: Infosys, Wipro 🔴 Fri 17: Reliance, Polycab ⚫ Sat 18: HDFC Bank, ICICI Bank, IndusInd Bank #EarningsSeason #StockMarketIndia #TechStocks #BankingSector #RelianceIndustries #Infosys #Wipro #ICICIBank #HDFCBank #AxisBank #IREDA #Polycab #InvestSmart #Nifty50 #Sensex #IndiaInvesting #FinTwitIndia #FinanceWithFree

🚨 LG Electronics IPO Listing View 🚨 Subscription frenzy ✅ Media buzz everywhere ✅ GMP soaring ✅ I’m a buyer below ₹1,600–₹1,700 levels. Short-term target: ₹2,000–₹2,200 Will accumulate more if it dips post-listing. This isn’t hype—it’s conviction backed by brand strength & long-term moat. Let the noise fade. I’m positioning for the next wave. #IPO #ipoupdates #ipoListing #ipoallotment #lgipo #IPOAlert #LGElectronics #ListingDay #SmartMoney #ConvictionPlay #StockMarketIndia #LongTermInvestor #BuyTheDip #WealthBuilding #FinanceWithFree

LG Electronics IPO 🚀 Listed at ₹1710 on NSE — a jaw-dropping +50% debut 💥 Massive gains for allottees. What a moment! 🤑 Pre-Diwali fireworks already 🔥 Congrats to everyone who got in early 🎉 LG Electronics listing day strategy shared below Let the noise fade. I’m positioning for the next wave. #IPO #ipoupdates #ipoListing #ipoallotment #lgipo #IPOAlert #LGElectronics #ListingDay #SmartMoney #ConvictionPlay #StockMarketIndia #LongTermInvestor #BuyTheDip #WealthBuilding #FinanceWithFree

Rubicon Research Limited IPO !!! All the Best 🙂 and Fingers crossed 🤞 for allotment 💰 👤 Retail: 1 out of 30 💼 SHNI: 1 out of 69 🏦 BHNI: 1 out of 23 Check allotment below in some time in.mpms.mufg.com/Initial_Offer/… #rubiconresearch #IPOAlert #IPO #IPOListing #Rubicon

🚨 Trump just dropped a $100,000 H‑1B visa bomb 🚨 Current fee? ~$1K–$5K. That’s a 20x+ jump. Here’s what it means for Indian IT, Big Tech & global talent 🧵👇 📊 Why it matters: - 71% of H‑1Bs go to Indians 🇮🇳 - Median H‑1B salary: ~$118K - New fee: $100K/year → eats up 80% of a mid‑level engineer’s pay For many, the U.S. dream just became economically impossible. 🏢 Company impact: - Infosys, TCS, Wipro, HCL → margins crushed - Amazon, Google, Microsoft → can absorb, but ultra‑selective - Startups/SMEs → priced out completely 🎓 Who gets hit hardest? - Indian students in U.S. Universities - Mid‑level engineers ($100K–$130K) - Consulting firms rotating staff Only ultra‑specialists ($200K+ salaries) may justify the fee. 🌍 Ripple effects: - India’s IT exports slow sharply - “Brain drain” reverses → more engineers stay in India - U.S. startups & labs lose affordable global talent 💸 The numbers are brutal. Annual bill @ $100K each: - Amazon: $387M - Cognizant: $284M - Infosys: $250M - TCS: $145M - Microsoft: $126M - Google: $106M - Meta: $92M - Wipro: $61M 👉 Top 20 firms = $2.52B/year 👨‍💻 For IT professionals: - Juniors → U.S. dream nearly shut - Mid‑levels → companies won’t justify $100K overhead - Top‑tier specialists → still in demand, but only at $200K+ 📉 For India’s IT sector: - Margin compression & stock volatility - Offshore delivery & GCCs in India accelerate - Freshers’ U.S. green card track may vanish 🔮 The $100K H‑1B fee = a gatekeeper tax - Big Tech survives - Indian IT bleeds - Startups & SMEs exit This isn’t just immigration policy — it’s a $2.5B annual wealth transfer to the U.S. Treasury. 💡 Bottom line: The $100K H‑1B fee is a seismic shift that could: - Reshape global IT supply chains - Redefine U.S. immigration policy - Force Indian IT to reinvent its U.S. strategy Do you think this kills the U.S. tech dream for Indian engineers? 👇 #h1bvisa #IndianIT #BigTech #H1BEmployer #H1bsponsorship #Trump #TrumpTariffs

Giveaway Alert! 🚨 We’re giving away the newly launched Apple iPhone 17 🔥 Want in? 🔁 Retweet this post ✅ Follow 👥 Tag 3 friends in the comments (Just mention any handles to qualify) It’s that simple good luck! 🤞 This giveaway is India-exclusive not international

@dealztrendz Tagging @WeLovePolygon @YouTubeCreators @KnowledgeisPi my friends to win this giveaway

📉 SME IPO LISTING REPORT CARD — 2 Sept 2025 🔻 NIS Management Ltd. IPO: ₹111 | Listed: ₹108 (-2.70%) Loss: ₹7,200 (Retail) / ₹10,800 (HNI) 🔻 GLOBTIER Infotech Ltd. IPO: ₹72 | Listed: ₹57.60 (-20%) Loss: ₹46,080 (Retail) / ₹69,120 (HNI) Retail pain is real. Due diligence > hype. #ipoallotment #iporates #IPOAlert #SMEIPO #StockMarketIndia #IPOWatch #ListingDay #InvestSmart #FinancialLiteracy #sme

🚨 SME IPOs Closing Today – Final Verdict 🧵 If you're applying, here's your last-minute deep dive 👇 1️⃣ Sugs Lloyd Ltd 🔧 EPC player in solar & electrical infra 💰 Price Band: ₹117–₹123 | Issue Size: ₹85.66 Cr 📊 FY25 Revenue: ₹176.2 Cr (+171% YoY) 📈 EBITDA: ₹27.47 Cr | PAT: ₹16.77 Cr (+93% YoY) 📉 PE: 17.02x | EV/EBITDA: 13.09x | ROE: 43.4% ⚠️ Balance sheet concerns despite strong growth #SugsLloydIPO #InfraStocks #SMEIPO 2️⃣ Snehaa Organics Ltd ♻️ Solvent recovery & recycling 💰 Price Band: ₹115–₹122 | Issue Size: ₹32.68 Cr 📊 FY25 Revenue: ₹26.29 Cr (+10% YoY) 📈 EBITDA Margin: 43.52% | PAT: ₹7.34 Cr (+101% YoY) 📉 PE: 11.99x | ROE: 49.66% | ROCE: 50.38% ✅ Strong margins & valuation comfort #SnehaaOrganicsIPO #GreenInvesting #SMEIPO 3️⃣ Abril Paper Tech Ltd 🧻 Sublimation paper manufacturer 💰 Fixed Price: ₹61 | Issue Size: ₹13.42 Cr 📊 FY25 Revenue: ₹60.91 Cr (+142% YoY) 📈 EBITDA: ₹2.01 Cr (+21% YoY) | PAT: ₹1.41 Cr (+52% YoY) 📉 PE: 34.46x | EV/EBITDA: 23.64x | ROE: 18.03% ⚙️ High growth, but thin margins & aggressive valuation #AbrilPaperTechIPO #PrintingTech #SMEIPO 🛑 I’m personally avoiding all 3 ❌ But if you're applying, do it with eyes open 👀 📅 Deadline: Today, Sep 2 📈 Listing: Sep 5 💡 Always read the RHP & assess your risk appetite #IPOAlert #RetailInvestors #SMEStocks #StockMarketIndia #IPOIndia #sme #ipogmp

Why 98% of Indians Don't Reach ₹1 Crore Net Worth 🧵 Just listened to a fascinating podcast with Kirtan Shah @KirtanShahCFP , Gajendra Kothari @gajendrakothari & Anirudh Garg @garganirudh breaking down the financial habits holding many Indians back. Here are the crucial takeaways for anyone aiming for financial freedom! #PersonalFinance #IndiaInvests #WealthCreation 1/ Stop Chasing a Number, Focus on Returns! 📈 Instead of fixating on ₹1 Cr, the real game is consistent CAGR (Compound Annual Growth Rate). That first Crore is the toughest, taking ~10 years. After that, compounding accelerates rapidly! Patience is paramount. #Compounding #FinancialDiscipline 2/ Beware the "Quick Money" Trap! 🚫 The "fast food" approach to investing (think F&O, Dream11 for quick bucks) is a wealth destroyer. Real wealth is built slowly and steadily, not through gambles. Resist the urge for instant gratification. #SmartInvesting #AvoidFOMO 3/ Skill & Income Growth BEFORE Investments! 🧑‍💻 This is HUGE. Before you can invest significantly, focus on upskilling to boost your income. More income = more savings = more to invest. Your earning power is your most potent asset. #CareerGrowth #FinancialPlanning 4/ Rethink Real Estate as a Primary Investment (especially for youth)! 🏠 Controversial, but valid: Low rental yields & the need for massive appreciation often make real estate a less efficient primary investment for young individuals. Consider delaying homeownership to let financial assets grow. #RealEstate #InvestSmart 5/ Credit & Consumption: The Silent Killers of Wealth. 💳 A consumption-driven culture fueled by easy credit (credit cards, BNPL) is a major obstacle. Learn to differentiate needs from wants, and be disciplined about debt. Live below your means. #DebtFree #FinancialLiteracy 6/ Favor Financial Assets Over Physical! 💰 Historically, financial assets like equities (through MFs, direct stocks) offer 12-18%+ returns, significantly outpacing physical assets like gold & real estate (6-10%). Align your portfolio with growth engines. #EquityInvesting #MutualFunds 7/ Embrace a Contrarian Mindset! 📉📈 "Be greedy when others are fearful, and fearful when others are greedy." This timeless wisdom means investing more when markets are down and being cautious during euphoric highs. It's tough but rewarding. #MarketWisdom #ContrarianInvesting 8/ Keep Investing Simple! 🚀 For most, trying to be a stock-picking guru without time/expertise is a recipe for disaster. Simple, disciplined investing in diversified mutual funds often yields better results. Outsource to professionals! #SIP #PassiveInvesting 9/ Wealth is a Tool, Not the Destination! ❤️ Ultimately, money serves a purpose: to support your life goals, health, and family. Don't get trapped in endless accumulation. Find balance between saving for tomorrow and living today. #LifeGoals #FinancialFreedom What are your thoughts on these points? Are you making any of these mistakes, or have you found success with these strategies? Share below! 👇 Link to the podcast by @NamaskarPrasad youtu.be/M4J2sdKd0SM?fe… #IndianEconomy #FinanceTips #InvestmentStrategy #PersonalFinanceIndia #Mumbai #Maharashtra

🔥 3 of India's sharpest investment minds on ONE stage. We listened, so you can profit. Chief Investment Officers Taher Badshah from @invescoindia , Vetri Subramaniam @VetriSmv& Neelesh Surana from @MiraeAsset_IN dropped some serious knowledge at "Power Talks". Here's their ultimate guide for YOUR money in 2025. 🧵👇 #Investing #StockMarketIndia #Finance #PowerTalks 🧘‍♂️ Vetri Subramaniam: The Voice of Calm & Discipline. His advice? Don't let global headlines become your personal financial crisis. 🔹 Geopolitics: Ignore the noise. STICK TO YOUR SIP. 🔹 Lump Sum?: Go for Hybrid Funds. Indian fixed income yields are attractive & tax-efficient. 🔹 The Golden Rule: Create a plan. Follow it religiously. NO emotional tinkering. Valuations & asset allocation are king. 🔹 BIGGEST NO: Borrowing to invest (leverage). Takeaway: Be the tortoise, not the hare. 🐢 #SIP #AssetAllocation #LongTermInvesting #FinancialPlanning 🇮🇳 Neelesh Surana: Betting Big on India, with a dose of Realism. He believes the domestic story is where the real money is. 🔹 Short-term Needs (3-5 yrs): Keep equities AWAY. Use safer options. 🔹 Mid & Small Caps: It's their time to shine! Give them a higher allocation in your portfolio. IPOs & formal economy are supercharging them. 🔹 Hot Sectors: Infra 🏗️, IT 💻, Banks 🏦, Hospitals 🏥, & Consumer Staples 🛒. 🔹 Reality Check: Expect "low teens" returns (12-15%) over 3-5 years. Stagger your investments to avoid disappointment. Takeaway: Go local, think small (caps), and be realistic. 📈 #IndianEconomy #Midcap #Smallcap #Nifty #StockPicks 🎯 Taher Badshah: The Architect of a Lean, Mean Portfolio. His mantra is simple: Focus wins. Stop collecting funds like Pokémon cards. 🔹 The ₹10 Lakh Formula: A simple, powerful allocation. 60% Equity (India + Global) equities 20% Gold & Silver 🪙 20% Fixed Income 📄 🔹 Future Opportunities (1-2 yrs): The Power Sector (generation/transmission) ⚡ and the New-Age Digital Consumer (travel, online). 🔹 Final Word: "Stay Focused." Over-diversification is a wealth killer. 5 good mutual funds are PLENTY. Takeaway: Quality over quantity. Build a concentrated, high-conviction portfolio. 🏆 #Portfolio #Gold #MutualFunds #Diversification So, what's the verdict from the Gurus? 🧘‍♂️ Vetri: Discipline is your superpower. 🇮🇳 Neelesh : India's growth is real, especially in smaller companies. 🎯 Taher: Focus your bets, don't just spread them . Three legends, one core message: Invest with a plan, not with panic. Whose strategy resonates with YOU the most? 🤔 Drop your choice in the comments! 👇 Link to the podcast by @powerup_money youtu.be/5Q2COrxwHD8?fe… #InvestLikeAPro #DalalStreet #WealthCreation #MoneyTalks #FinancialFreedom

IPO Reality Check! 🥶 Today’s listing "gains" on #DalalStreet: ⚙️ Vikran Engineering: +₹296 💊 Anlon Healthcare: +₹164 Your listing day party budget might just cover a vada pav. 🥲 A stark reminder that not every IPO is a lottery ticket. Apply wisely! #IPOListing #StockMarketIndia #Investing #RealityCheck #IPOAlert #ipoallotment #IPOs #VikranEngineeringIPO #ANLON

BOOM! 💥 The SME IPO board is ON FIRE this morning! While the mainboard snoozed, the real party was here on #DalalStreet: ⚡️ CURRENT INFRASTRUCTURE SME: Explodes on listing with a 90% GAIN! That's a whopping ₹2.3 LAKH profit on a single application. 🌿 SATTVA ENGG SME: A solid debut with a 26% POP! Bagging investors a cool ₹64k profit. The small caps are making big noise today! #SMEIPO #IPOListing #StockMarketIndia #Blockbuster #IPOAlert #ipoallotment #ipogmp #IPOs #currentinfra #sattva

🤯 STOP CHASING RETURNS, START CHASING DISCIPLINE! 🤯 Just watched an incredible interview with financial wizard Kirtan Shah @KirtanShahCFP and my mind is BLOWN. Forget complex market analysis, his approach to building wealth is refreshingly simple yet profound. This isn't just about money, it's about mindset! Here are my 🔥 TOP 5 TAKEAWAYS 🔥 you NEED to know: 1️⃣ DISCIPLINE > KNOWLEDGE! 🧘‍♂️ Kirtan says most people fail not because they don't know, but because they LACK DISCIPLINE. Stop jumping between investments based on short-term noise. Pick a plan, stick to it. PERIOD. #FinancialDiscipline #InvestSmart #LongTermThinking 2️⃣ THE 1 CRORE SECRET on 1 LAKH SALARY! 💰 YES, it's possible! Invest ₹25K/month @ 12% returns = ₹1 CRORE in ~14 years. The real magic? Each subsequent crore comes FASTER thanks to compounding! 🚀 Your first crore is the hardest, but it builds momentum! #MillionaireMindset #WealthBuilding #CompoundingMagic 3️⃣ RENT vs. BUY? The SHOCKING TRUTH! 🏠 Kirtan makes a COMPELLING case for renting over buying from a pure financial perspective. The money you save on down payment + EMI difference, INVESTED, can make you WAY wealthier over 20 years. This will challenge everything you thought you knew! #RentDontBuy #RealEstateReality #FinancialFreedom 4️⃣ PREPAYING LOANS? THINK AGAIN! 💡 Counter-intuitive but brilliant! Especially in the latter half of a loan, prepaying might NOT be your best move. Tax benefits + higher market returns often mean investing that extra cash yields more than saving on loan interest. #SmartMoneyMoves #LoanStrategy #DebtManagement 5️⃣ THE MILLIONAIRE'S HABIT STACK! ✨ AVOID: Complicated schemes, F&O trading (93% lose!), frequent switching. EMBRACE: Increasing investments as income grows, focusing on your main job to earn more, consistent SIPs. It's not about being a market guru, it's about CONSISTENCY! #HabitsOfWealth #GetRichSlow #FinancialWellness This interview is a MASTERCLASS in practical wealth creation. Seriously, go watch it! Link below of the YouTube video by @Financially_In youtu.be/yjqwSUdTZpM?fe… What's your biggest takeaway? Let me know below! 👇 #KirtanShah #MoneyTalks #PersonalFinance #InvestForFuture #WealthCreation #FinancialLiteracy #MindsetMatters #ViralFinance #SIPs #RentingIsBetter

Amanta Healthcare IPO: To apply or not? 🤔 I've been digging into the details of the Amanta Healthcare IPO, and it's a fascinating case. They have a "crown jewel" product, but some serious red flags are waving. 🚩 Here's my deep-dive analysis, and why I'm ultimately SKIPPING this one. A thread... 🧵 The Crown Jewel 👑 - SteriPort First, the good stuff. Amanta's flagship product, SteriPort, is a premium two-port IV fluid container. It's a high-margin product growing at ~15% CAGR and makes up a big chunk of their domestic sales. This innovation gave them a first-mover advantage back in 2016. But is that advantage still strong today? The Anchor Book Analysis ⚓ The company raised ₹37.8 crore from six anchor investors. The key participants include Bandhan Small Cap Fund, Sanshi Fund, and Perpetuity H2W Rising Fund. While the presence of institutional investors is a positive sign, the overall anchor book size is not overwhelmingly large, which warrants a closer look at the company's fundamentals. The Debt Bomb 💣 Here's where it gets worrying. The company is swimming in debt. Interest costs are eating up 50-60% of their EBITDA! They even needed a ₹68 crore debt waiver from KKR Finance in 2022 after restructuring. Plus, some promoter holdings are pledged. That's a lot of financial pressure. The Trust Deficit? 🧐 A look at their history raises questions. 🔹 A substandard product quality case from 2013 is still ongoing. 🔹 Their factory license was briefly suspended in 2015. 🔹 An attempt to get a US FDA license resulted in 19 observations, and they eventually backed off. For a pharma company, this history is a major concern. 5/8: The Growth Story Timeline 🗓️ The IPO funds are for expansion, which is great. But here's the catch: ➡️ SteriPort capacity doubles from... Jan 2026. ➡️ Small Volume Parenteral capacity expands by... FY27. The growth you're paying for today won't be fully realized for another 2-3 years. The Price Tag is STEEP! 💰 This is the deal-breaker for me. The IPO is priced at a P/E of ~46x based on FY25 earnings. For a company with modest 10-15% projected growth, slow sales in FY25, and the risks mentioned, this valuation feels incredibly aggressive. Peers like Denis Chem trade at a much lower 16x P/E. The Final Verdict ⚖️ When you combine: ➡️ Steep Valuation (46x P/E) ➡️ High Debt & Pledged Shares ➡️ Past Quality & Regulatory Hurdles ➡️ Growth benefits kicking in late (FY26-27) The risk/reward balance just doesn't seem favorable. The smaller issue size also adds to the volatility risk. My Call: AVOID Despite the interesting SteriPort product, the fundamentals are too shaky for the price being asked. It feels like paying a premium for a story that has yet to fully play out, with significant risks along the way. What are your thoughts? Are you applying or giving it a pass? Let me know below! 👇 #IPO #AmantaHealthcare #IPOAlert #StockMarket #Investing #IndianStocks #StockAnalysis #PharmaIPO #WealthCreation #InvestmentStrategy #StockMarketIndia #ipoallotment #IPOs #IPOListing

📉 SME IPOs: Today's Listing Report Card 🧾 Had personally skipped all the 3 ipos. View shared in the below tweet. Retail investors, brace yourselves. The SME street was brutal today. 🔹 SNEHAA (NSE SME) 📌 IPO: ₹122 | 📈 Listed: ₹122 🟰 Flat debut. No gains, no pain. #NeutralListing #SMEWatch 🔹 SUGSLLOYD (BSE SME) 📌 IPO: ₹123 | 📉 Listed: ₹119.90 💸 Individual Loss: ₹6,200 💸 HNI Loss: ₹9,300 #RedStart #IPORealityCheck 🔹 ABRIL (BSE SME) 📌 IPO: ₹61 | 💔 Listed: ₹48.80 🔥 Individual Loss: ₹48,800 🔥 HNI Loss: ₹73,200 #AbrilAgony #SMEBloodbath 🧠 Lesson: SME IPOs ≠ guaranteed listing gains. Due diligence > hype. 📢 Retail warriors, protect your capital. 📊 Follow for real-time IPO insights, risk flags & post-listing truth bombs. #IPOAlert #SMEStocks #RetailInvestor #StockMarketIndia #IPOGainsOrPains #FinancialLiteracy #BSESME #NSESME #InvestSmart #MarketReality #SMEIPO #ListingDayDrama #ipolisting #ipoallotment